Abstract
INTRODUCTION
The classic Norwood procedure remains a high-risk surgical procedure in neonates with hypoplastic left heart syndrome (HLHS). Although authors from high-volume centres report a death rate close to 15% after Stage 1 Norwood procedure, most multicentre studies report that 1/4 to 1/3 of neonates with HLHS with initial palliation die before discharge or during the interstage period [1] [2] [3] [4] . The period around Stage 1 of the Norwood procedure has been identified as high risk for mortality and morbidity. Moreover, the Norwood procedure performed in small-volume centres is associated with significantly more deaths [5] [6] [7] . Checchia et al. [7] , in their retrospective multi-institutional study, report an overall survival rate at hospital discharge of 68% with a mortality rate varying from 0% to 75% in small-volume centres (<16 cases/year). Therefore, in 2005, Galantowicz et al. [8] introduced a hybrid strategy for the management of HLHS as an alternative surgical palliation strategy to decrease early deaths. This technique includes banding of the pulmonary arteries (PA) concomitantly with the stenting of patent ductus arteriosus (PDA) associated with atrial septoplasty if required. It is less invasive than classic Stage 1 palliation and avoids neonatal cardiopulmonary bypass (CPB). Although this combined surgical and interventional cardiological technique shows excellent results in terms of interstage 1-2 survival, it has major disadvantages: recurrent angioplasty or stenting for PDA stent migration, anterograde blood flow obstruction through the PDA, retrograde stenosis into the transverse aortic arch and long CPB and cross-clamping times during Stage 2 [9] . Moreover, it requires the simultaneous availability and collaboration of 2 teams: paediatric cardiothoracic surgeons and interventional cardiologists.
The new technique we describe is inspired by the hybrid approach for HLHS, but instead of stenting the PDA, we replace the PDA by a pulmonary homograft that is then used to create the neo-ascending aorta in Stage 2 palliation.
METHODS

Description of the surgical technique
Stage 1
The twin goals of our new technique meet those of the hybrid Stage 1 palliation: maintain unobstructed systemic output through a PDA (reconstructed by a pulmonary homograft in our technique, by stenting in the hybrid palliation) and improve the balance of the pulmonary and systemic circulations. The surgical technique is illustrated in Fig. 1 and in Video 1.
With the patient under general anaesthesia, after median sternotomy, thymectomy and vertical opening of the pericardium, CPB was initiated between the innominate artery and the 2 vena cavas. The patent ductus was ligated after initiation of CPB and the atrial septum was resected via the right atrium while the body temperature was cooled to 24 C. A pulmonary homograft was tube shaped on a Hegar dilator with an inner diameter of 9-10 mm. The aorta was clamped using a Cooley clamp between the innominate artery and the left common carotid artery. Cerebral and coronary artery perfusion was then ensured by inserting the aortic cannula in the innominate artery; no cardioplegia was required. The PDA was resected, and the pulmonary homograft was anastomosed distally to the descending aorta, the aortic arch and the distal atretic ascending aorta right after the Cooley clamp. This clamp was then released from the aorta and positioned on the pulmonary homograft to offer full vascularization of the body. Then, the pulmonary homograft was anastomosed proximally to the pulmonary root. Initially, the PA were banded using bands fashioned by cutting a 1-2-mm ring from a 3.5-mm GoreTex tube graft for the right PA and a 3-mm GoreTex tube graft for the left PA. Because of the initial results of surgery, we decided to tighten the PA bands: We inserted a 2.5-mm Hegar dilator sequentially in both the right and left PA and performed the banding using a GoreTex suture tied on the Hegar dilator. The left PA band was placed immediately after the point where it originates from the main PA. The right PA band was positioned between the ascending aorta and the superior vena cava. Once positioned, the bands were tacked to the local adventitia to prevent band migration.
Interstage
After discharge, the patients were closely followed: echocardiographic assessment was done 1 month after discharge and before Stage 2 cardiac catheterization.
Echographic assessment was used to monitor blood flow in the pulmonary homograft, evolution of the atretic ascending aorta, placement and gradient of the PA bands, right ventricular function, and analysis of the tricuspid valve. Whenever the results of this interstage assessment were abnormal or if the patient was symptomatic, the patient was examined with either computed tomography or angiography.
Pre-stage 2 cardiac catheterization was used to evaluate pulmonary vascular resistance and to determine whether it was safe to proceed with Stage 2, to analyse the systemic blood flow in the pulmonary homograft, the ascending and the descending aorta and to detect any PA distortion due to PA banding.
The patients were scheduled for Stage 2 when they were 4-6 months of age.
Stage 2
The second procedure, through redo median sternotomy, comprises the reimplantation of the atretic ascending aorta to the pulmonary homograft and a bidirectional cavopulmonary shunt. After we carefully opened and dissected the chest, we initiated Video 1: Under CPB with bicaval cannulation and arterial cannulation in the innominate artery, the interatrial septum is resected via right atriotomy. The patent ductus arteriosus is replaced by a T-shaped pulmonary homograft while bilateral PA banding is performed using a GoreTex suture that is tight on a Hegar dilator.
CBP via selective anterograde cerebral perfusion, with an arterial cannula in the innominate artery and a cannula in each vena cava. Body temperature was cooled to 24 C. The ascending aorta was transected and the 2 pulmonary branches were separated from the reconstructed ductus, i.e. the pulmonary homograft. The PA were debanded and the pulmonary bifurcation was reconstructed with a pericardial patch. If necessary and because of tight banding, one can do a plasty of one of the branch PAs using the same pericardial patch. Both the atretic ascending aorta and the pulmonary homograft were incised longitudinally. The atretic ascending aorta was then sutured to the pulmonary homograft to recreate a functional and wide neo-ascending aorta. A bidirectional superior cavopulmonary anastomosis was created between the superior vena cava and the PA as described for Stage 2 palliation in the classic Norwood procedure.
Patients
From July 2014 to May 2016, 15 patients underwent this new surgical approach. All parents had prenatal counselling during pregnancy. If their choice was to have the baby rather than to terminate the pregnancy, despite the poor prognosis of HLHS, all therapeutic options were discussed: compassionate neonatal care, the classic Norwood procedure, the hybrid technique and the new surgical hybrid approach. All parents whose child underwent the new surgical approach gave their full consent for surgery.
Statistical analysis
Patients were divided into 2 groups (Group 1: right PAB 3.5 mm/ left PAB 3 mm; Group 2: bilateral PAB 2.5 mm). Continuous data are expressed as median and range. Categorical data are expressed as number and percentage. Univariate analysis was performed using either the Chi-square test or the Fisher's exact test for categorical data, and the Student t-test for continuous data.
Data were analysed with the GraphPad software (version 7, GraphPad Software, La Jolla, CA, USA). Table 2 compares the characteristics of patients in Groups 1 and 2. Thirteen patients had a diagnosis of HLHS with aortic atresia/mitral atresia; 1 patient, a double inlet right ventricle with malposition of the great arteries and aortic atresia; and 1 patient, a tricuspid atresia with malposition of the great arteries and aortic atresia. Median age and weight at intervention were 5 days (1-8 days) and 3.0 kg (2.3-3.9 kg), respectively. Median CPB time was 78 min (61-108 min) with selective perfusion of the innominate artery and the coronary arteries for 15 min (12-23 min). Median length of stay in the intensive care unit (ICU) after intervention was 11 days (6-104 days). Thirteen patients (87%) were initially discharged from the hospital. One patient died in the ICU of low-cardiac output and sepsis 1 month after the operation. One patient needed mechanical support by central extracorporeal membrane oxygenation for 8 days after initial palliation. He had recurrent respiratory infections associated with tricuspid regurgitation that required hospitalization in the ICU until Stage 2 intervention.
RESULTS
Operative and postoperative characteristics
Interstage mortality
The interstage mortality rate was 28% (4/14): 3 patients in Group 1 (3/7; 42.8%) and 1 patient in Group 2 (1/7; 14.2%). The 4 patients had been discharged from the hospital at a median delay of 17 days (14-24). Two patients died of ventricular failure. Sudden death was the cause of death for 1 patient. The parents did not allow an autopsy, but a cardiac angiogram and a CT scan taken 1 week before death showed good patency of the ascending aorta, pulmonary homograft and PA; good coronary perfusion; and no pulmonary artery distortion or obstruction by the banding. One patient from Group 2 died of digoxin overdose.
Stage 2
Nine patients (60%) underwent the Stage 2 procedure, i.e. anastomosis of the pulmonary homograft to the ascending aorta, detachment of the pulmonary bifurcation, and bidirectional cavopulmonary shunt. One patient is still waiting for Stage 2. The mean delay between initial palliation and Stage 2 was 3.9 months (3.1-6.0 months). Median CPB time was 154 min (125-211 min) with a median aortic cross-clamp time of 75 min (56-106 min). Three patients required plasty of the left PA with a pericardial patch: The left PA was stenotic but not occluded after debanding. Eight patients were still alive at the last follow-up examination; 1 patient died 3 months after Stage 2. This patient had recurrent respiratory infections associated with tricuspid regurgitation and remained in the ICU until Stage 2 intervention. He had required 8 days of mechanical support by central extracorporeal life support During Stage 2 intervention, a first tricuspid repair was performed. He was discharged from the ICU 23 days after Stage 2 but required another tricuspid valve repair 1 month later for recurrent tricuspid regurgitation. A second repair showed good initial haemodynamic results on echocardiographic scans (no trivial regurgitation, no gradient) and allowed weaning from mechanical ventilation. Unfortunately, he had septic shock with perforation of the anterior tricuspid leaflet that led to severe tricuspid regurgitation, ventricular dysfunction and death.
Comparison with classic Norwood
We compared the results of our new surgical approach with our poor results using the classic Norwood procedure for neonates with HLHS. We found significant differences in CPB and selective perfusion times (P < 0.0001), need for delayed chest closure (P < 0.0001) and in-hospital deaths after surgery (7% vs 43%; P = 0.0074), in favour of the new surgical hybrid approach (Table 3) . Death before Stage 2 (in-hospital death and interstage death) and interstage deaths were lower with the new surgical hybrid procedure than with the classic Norwood procedure (33% vs 62%; P = 0.0792 and 32% vs 28.5%; P = 0.0812, respectively).
Although not significant, postoperative complications such as the need for extracorporeal membrane oxygenation, mechanical ventilation, inotropic support, or peritoneal dialysis was higher with the classic hybrid Norwood procedure. Median stays in the ICU and hospital decreased by 6 and 4 days, respectively, with the new surgical hybrid procedure.
DISCUSSION
HLHS is the most lethal congenital heart disease. Without any surgical management, 90% of the affected patients die during the first month of life [10, 11] . When HLHS is diagnosed prenatally, parental counselling is essential to inform the parents of the incurable nature of this disease that can only be palliated by subsequent high-risk surgical procedures. Three options are presented to the parents: termination of pregnancy, comfort care after birth, or palliative surgical management. In our country, the Norwood procedure is rarely proposed to parents and is performed in only a few centres [12] . Heart transplant is never proposed nor done at this age, because neonatal organs are scarce or nonexistent and because of the poor long-term prognosis of the patients receiving the transplant. Thus, the termination of pregnancy rate for foetuses with univentricular hearts is high in comparison with other countries, over 60%, and HLHS prevalence remains low: 1.5 for 10 000 live births, fewer than 15 HLHS cases in the greater Paris area per year [13, 14] . If parents choose not to terminate pregnancy, delivery and immediate management in a cardiac surgical centre is necessary Group 2 patients had tightening of the PA bands from 3.5 to 2.5 mm with no hospital deaths and low-interstage deaths. AVVR: atrioventricular valve regurgitation; CPB: cardiopulmonary bypass; ICU: intensive care unit.
because presurgical neonatal mortality rates remain high [15] . The Norwood procedure for HLHS is the most complex and highest risk existing procedure in the field of paediatric cardiac surgery. Current management at major international paediatric heart centres has resulted in survival rates of 75% and more, but in small volume centres, mortality rates can be as high as 75% [1, [3] [4] [5] . The international published data do not reflect the reality of the postoperative prognosis of the initial palliation because centres, including ours, with the poorest results are not enthusiastic about publishing their series. A slightly better understanding of the results could be achieved by analysing the Society of Thoracic Surgeons (STS) and European databases, but again, the analysis would not provide a realistic picture.
To address the issue of the high-mortality rate after Stage 1 palliation in HLHS patients, Galantowizc et al. [8] developed the hybrid procedure, a combination of surgical and interventional techniques, to increase early and interstage survival until patients reach the ideal age for Stage 2 palliation. To develop the hybrid procedure in our unit, we faced problems in terms of organization and cooperation between healthcare professionals and time and had the same results as conventional palliation by the Norwood procedure. In our institution, because we have less than 1 patient with HLHS per month, the mortality rate remains high, independent of the years of surgery and the surgeons. Moreover, the morbidities of these patients and the level of intensive care required (nurses, intensivists, and surgeons) had a real impact on the global care of other patients (1 nurse for 2 beds and 1 intensivist for 8 beds in the ICU). We then thought to develop a new palliative operation, inspired by the hybrid technique, by replacing the PDA with a pulmonary homograft while banding both the PA. The concept was to simplify the initial palliation; avoid aortic cross-clamp, myocardial ischaemia, and ventriculotomy; and leverage the advantages of the hybrid procedure without the potential disadvantages (necessity for hybrid suite, early and late complications of PDA stenting including coarctation and retrograde malperfusion, need for secondary arch repair). In this initial cohort, the early mortality rate was 6.7% (1/15) and the interstage mortality rate was 28.5% (4/14) leading to an overall mortality rate before Stage 2 of 33% (5/15). In the first group of 8 patients, the number of deaths was high, mainly due to ventricular dysfunction during the interstage period. We hypothesized that it was due to increase of pulmonary blood flow when pulmonary resistance decreased, resulting in coronary steal, myocardial ischaemia and circulatory instability. To overcome this main issue, we tightened the bands from 3.5 to 2.5 mm in the following 7 patients. In the second group of patients with tightened bands, there were no in-hospital deaths and only 1 interstage death due to drug intoxication. No other patient from this group showed evidence of ventricular dysfunction before Stage 2.
Although our mortality rate decreased with this new surgical procedure, it remains high compared to the results of the Norwood procedure in expert large-volume centres. This new surgical strategy was designed for small-volume centres whose outcomes with the classic Norwood procedures are disappointing and who lack access to a secure hybrid strategy.
A new surgical procedure is often associated with poor results in the beginning due to the learning curve. When the hybrid procedure for HLHS was initially introduced, the mortality rate among the first patients was high: Of the first 10 patients, 6 died before Stage 2 and only 1 of the 4 who completed Stage 2 was still alive at the last follow-up [8] . Modification of the combined interventional and surgical techniques allowed decreasing perioperative and interstage mortality rates.
Two major conclusions can be drawn from our study for our own interest. First, although the overall mortality rate remains high, it was twice reduced compared to that of the classic Norwood procedure in our centre (from 62 to 33%). Secondly, the in-hospital death rate was low (6.7%), the majority of the deaths occurring after discharge. Tightening the PA bands reduced both in-hospital and interstage deaths in a small cohort of patients.
In our country, no home-monitoring program exists for this type of risky patient. Some authors reported a drastic decrease in interstage mortality rates, from 12-15% to 0-2% in their coordinated home-monitoring program, which included daily oxygen saturation and weight recording [16] [17] [18] . They recommend that the parents notify the care team when oxygen saturation is <75% or >90%, weight gain is <20 g over 3 days or weight loss is > 30 g. Such a program does not exist in our country but should be developed for interstage surveillance after palliation. We therefore completely reorganized our outpatient clinic for these specific patients with a clinical appointment every week and cardiologists dedicated to this follow-up.
CONCLUSION
A new surgical neonatal palliation consisting of replacement of the PDA and aortic arch plasty with a pulmonary homograft, associated with both PA banding and atrial septectomy, was developed to decrease early and interstage mortality rates and time consuming, costly morbidities in HLHS patients managed in small-volume centres. Although we report an improvement in our outcomes, the number of deaths remains high, especially in the interstage period, raising the question of home monitoring for these high-risk patients. After the initial learning curve, larger series are necessary to provide further results and to determine if palliation might be useful for patients with this complex condition.
